In May 2019, NeoVirTech has been recognized by Pharma Tech Outlook Magazine as Top 10 Drug Discovery & Development Consulting/Services Companies in Europe. This annual listing highlights 10 companies that […]
NeoVirTech closes a 2 year research program with financial support from the 2016 I-Lab Contest by Bpifrance, in the category creation-development. This program aimed at developing autofluorescent veterinary viruses to […]
NeoVirTech was involved in this article investigating the activity of Sephin 1 as antiviral against a large variety of viruses. This work has been published in Frontiers in Immunology, in […]
NeoVirTech is now equiped with a new Thermo Scientific CellInsight CX7 confocal spinning disk high content screening microscope. Combined with the power of our autofluorescent viruses, this microscope allows us […]
Following several years of development of the ANCHOR technology, we are very proud to publish two bact-toback articles investigating real time infection of herpes viruses and adenoviruses. Both articles have […]
NeoVirTech announces the generation of autofluorescent baculoviruses and the corresponding patent protection. Following collaboration with Dr Miguel Lopez-Ferber from the IMT Mines Alès, NeoVirTech has validated autofluorescent ANCHOR tagging of […]